CAMT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Camtek Ltd is a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. My view is positive because the stock has strong analyst support, improving 2026-2027 revenue visibility, and a constructive business outlook tied to AI, advanced packaging, and HBM demand. The current price is near a key resistance area, but the overall setup still favors buying now rather than waiting, especially since the investor is impatient and wants exposure without trying to time a perfect entry.
CAMT is in a mildly constructive trend with mixed short-term momentum. Price closed at 173.6 after trading around 174.78 previously, with the stock still close to R1 at 175.906 and above the pivot at 163.933. RSI_6 at 56.2 is neutral-to-slightly bullish, while MACD histogram at -0.814 is still below zero but contracting, which suggests downside momentum is fading. Moving averages are converging, pointing to a transition phase rather than a strong breakdown. The technical picture is not explosive, but it is supportive for a long-term entry near current levels.
Management commentary pointed to Q2 revenue guidance of $129M-$131M and second-half 2026 revenue more than 25% above the first half, supported by record orders and over $260M expected 2026-2027 revenue from two HBM customers. This is a strong fundamental catalyst tied to AI and advanced packaging demand.
Near-term hesitation comes from valuation concerns and mixed Wall Street positioning. Stifel downgraded the stock to Hold because it was already near the price target, and Northland said earnings power still does not justify a meaningfully higher share price. The stock also had a sharp 16% post-earnings pullback from elevated expectations, showing that sentiment can cool quickly when the bar is high. Technically, MACD is still negative, so momentum has not fully confirmed a breakout yet.
The latest quarter was Q1 2026, and it was a beat-and-raise report. Revenue came in slightly ahead of expectations, and management raised guidance for Q2 to $129M-$131M. More importantly, the company guided second-half 2026 revenue to be more than 25% higher than the first half, indicating strong growth acceleration. The firm also highlighted record orders and visibility into 2027, which supports a positive medium-term growth trajectory.
Analyst sentiment is broadly bullish. Several firms raised price targets, led by BofA, Evercore ISI, Oppenheimer, Jefferies, Barclays, and B. Riley, while maintaining Buy/Outperform-style ratings. The main bearish counterpoint is Northland's Market Perform and Stifel's Hold, both focused on valuation rather than business weakness. Overall, Wall Street sees strong upside potential but acknowledges that the stock is not cheap. The pros view is stronger than the cons view.
